Skip to main content
Medicīniskā fizika
International Cooperation
Radiology

Assoc. Prof. Maija Radziņa, Lead Researcher at the RSU Faculty of Medicine’s Department of Radiology, in close collaboration with the RSU Faculty of Medicine’s Department of Physics (Asst. Prof. Jevgenijs Eugene Proskurins), actively participated in the organizing committee of the PRISMAP School Current and Innovative Radionuclides for Medical Imaging and Therapy, which was held in Rīga 19–21 February.

prismap_00.png

This was a great opportunity to explore the latest innovations in nuclear medicine and establish connections with experts and colleagues from across Europe.

The event aimed to provide insight into current and innovative radionuclides for medical imaging and therapy, showcasing various advancements in the multidisciplinary field of nuclear medicine, including radiopharmaceutical sciences, radioisotope production, clinical applications, and technological solutions.

This prestigious school brought together medical doctors, radiology and nuclear medicine professionals, radiology assistants and radiographers, medical physicists, young researchers, Master's and PhD students in nuclear medicine, physics, and chemistry from the Baltics and across Europe.

The participants were introduced to the latest trends in radiopharmaceutical sciences, including radiation chemistry, nuclear and particle physics, radionuclide synthesis, and dosimetry.

The school featured several theoretical lectures on topics such as the fundamental principles of nuclear and radiation physics, radioligand theranostics—precision nuclear medicine and molecular imaging, numerous scientific sessions, a public event, and additional activities.

The programme also included a visit to the Cyclotron facility in Riga and networking events to foster professional connections.

prismap_01.png

PRISMAP is a pan-European programme that provides access to innovative medical radionuclides and infrastructure, supporting research in this field across Europe and beyond.

The programme has established a European infrastructure network, which includes production facilities – nuclear reactors and particle accelerators – and radiochemistry laboratories.

PRISMAP Objectives

  • Research on new radionuclide production technologies
  • Development and transfer of isotope purification methods to preclinical research

Follow us on LinkedIn for the latest updates!

PRISMAP is funded by the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No. 101008571 (PRISMAP).